Company Data
AlloVir Inc.
Ticker
ALVR
Current Price
$9.63 -2.03%
Market Cap
$48.5M
Price Target
Refer to Report
Volume
5.1K
52wk Range
$7.96 - $24.15
Overview
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm’s pipeline includes ALVR106, ALVR109, ALVR108, and others. The company’s product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.